United Kingdom· GB-APID-435711000001108
Sonata 10mg capsules
A zaleplon product containing zaleplon, registered in United Kingdom by Meda Pharmaceuticals Ltd. The same ATC class is registered in 5 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Zaleplon is registered in 5 of 19 countries.
Countries holding a registration under ATC N05CF03 (zaleplon), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 4 of them publish a price we can compare per daily dose
Zaleplon · ATC N05CF03
5 / 19 countries
- Belgiumprice
- Finlandprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Zaleplon
- Manufacturer
- Meda Pharmaceuticals Ltd
- Country
- United Kingdom (GB)
- ATC code
- N05CF03
- ATC class
- Zaleplon
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5010981001441
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
176 interactions on record for zaleplon.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Zaleplon · interactions on record
176 records
- 4 severe
- 72 moderate
- 7 minor
- 83 info
Most severe, free to view
- MorphineN02AA01severe
- MorphinN07BC09severe
- HydrocodoneR05DA03severe
- CodeineR05DA04severe
10 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Zaleplon in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StateszaleplonPreferred Pharmaceuticals Inc.
- FinlandSonataMEDA AB
- BelgiumSonata 10 mgMeda
- PolandMorfeoAdamed Pharma S.A.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Poland · Morfeo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b6d01b90-51ea-44c4-95ae-91ab417e9303 GET /v1/drugs/b6d01b90-51ea-44c4-95ae-91ab417e9303?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "435711000001108",
"desc": "Sonata 10mg capsules (Meda Pharmaceuticals Ltd)",
"form": "Oral capsule",
"vpid": "42138611000001106",
"source": "dmd",
"vtm_id": "777968007",
"strength": "10 mg",
"substance": "Zaleplon",
"ingredient": "Zaleplon",
"supplier_code": "3312911000001106"
}See everything about zaleplon.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.